• Increase
  • Decrease
  • Normal

Current Size: 100%

  • International Affiliate Members at Ed Forum 2019
    IWMF International Affiliates

    IWMF President, Carl Harrington, and Elena Malunis, IWMF Vice President of Member Services, at the 2019 Ed Forum with International Affiliate members.

  • Peter DeNardis
    The IWMF Is Here to Help You!

    Click on the image to view a video of Peter DeNardis, IWMF Board Member, as he explains how the Foundation helps everyone affected by WM.

  • Ed Forum 2019
    Imagine a Cure

    We have a goal of raising $25,000,000 to support WM research and vital member services through both current gifts and legacy gifts.

  • Ed Forum 2019 in front of Philadelphia Art Museum
    Living with WM

    There are many patients with Waldenstrom’s macroglobulinemia (WM) who are living well and enjoying life with a degree of contentment that may seem surprising to others.

  • Ed Forum walk June 2019 in Philadelphia
    IWMF Members

    All photos on our site are of IWMF members. 

We support everyone affected by Waldenstrom's macroglobulinemia
while advancing the search for a cure.

News

September 12, 2019

With an emphasis on WM, the IWMF 2019 Human Intravenous Immunoglobulin Therapy (IVIG) Fact Sheet explains how the therapy is given, side effects, and self-care tips.

September 5, 2019

Preliminary results of WM patients in the LLS Patient Registry are now available. The IWMF and CLL Society were the first two lymphoma organizations invited to participate.

August 16, 2019

An exciting leadership change is taking place to enable the IWMF to better serve our members, affiliates and partners, and to enhance our search for a cure!

Events

September 25, 2019
585 University Ave
Toronto , ON
Canada
September 26, 2019
1500 Alta Vista Drive
Ottawa , ON
Canada
September 28, 2019
Bron
France
September 28, 2019
50 Waugh Drive
Houston , TX
United States
September 29, 2019
1227 Parkview Blvd
PA
United States

This website is supported in part by unrestricted educational grants from Pharmacyclics LLC  and Janssen Biotech, Inc.